Altria Group, Inc. (MO) Q3 2024 Earnings Call Transcript Summary
Altria Group, Inc. (MO) Q3 2024 Earnings Call Transcript Summary
Confirmed full-year adjusted diluted EPS guidance for 2024 in the range of $5.07 to $5.15.The following is a summary of the Altria Group, Inc. (MO) Q3 2024 Earnings Call Transcript:
以下是奧馳亞集團（Altria Group, Inc.）2024年第三季度業績會實錄摘要：
Financial Performance:
金融業績：
Altria Group reported Q3 2024 adjusted diluted earnings per share growth of 7.8% and 1.6% for the first nine months.
Adjusted operating company income for the Smokable Products segment grew by 7.1%.
Confirmed full-year adjusted diluted EPS guidance for 2024 in the range of $5.07 to $5.15.
Altria Group報告，2024年第三季度調整後攤薄每股收益增長7.8％，前九個月增長1.6％。
可調整運營公司收入菸草產品部門增長了7.1％。
確認2024年全年調整後攤薄每股收益指導區間爲5.07至5.15美元。
Business Progress:
業務進展：
NJOY's consumable shipment volume grew more than 15% to 10.4 million units and device shipment volume nearly tripled.
on! oral nicotine pouches grew 11.4 share points, now representing nearly 44% of the oral tobacco category.
Initiating the 'optimize and accelerate' initiative to modernize processes and aim for $600 million in cost savings over five years.
NJOY的消耗品發貨量增長了15％以上，達到了1040萬個單位，設備發貨量幾乎翻了一番。
on!口腔尼古丁袋的增長了11.4個份額點，現在幾乎佔口腔菸草類別的44％。
啓動"優化和加速"計劃以現代化流程，力爭在五年內實現60000萬元成本節約。
Opportunities:
機會：
The e-vapor category grew due to the increase in adult vapers, reflecting opportunity for smoke-free product penetration.
Regulatory actions to control illicit vapor products could enhance market conditions for compliant operators like Altria.
電子霧化類別增長是因爲成年使用者增加，反映出無煙產品滲透的機會。
規範行動控制非法霧化產品可能會增強像奧馳亞這樣的合規運營商的市場條件。
Risks:
風險：
Increased presence of illicit nicotine and vapor products impacting market dynamics and consumer choices.
Legal challenges with JUUL over patent infringements could affect NJOY's product availability.
非法尼古丁和霧化產品的增加對市場動態和消費者選擇產生影響。
由於JUUL在專利侵權上的法律挑戰可能會影響NJOY的產品供應。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
